Dr. Zhenping Zhu
Independent Non-executive Director
Dr. Zhenping Zhu is our independent non-executive Director, and is responsible for supervising and providing independent advice to our Board.
Dr. Zhu has approximately 30 years of experience in the pharmaceutical industry and innovative drug research development. Prior to joining our company, Dr. Zhu had positions in various biopharmaceutical companies, including ImClone Systems Inc., Novartis Pharma AG, Six Swiss Exchange, and Kadmon Corporation. After that, Dr. Zhu successively served as the president of research and development and the chief scientific officer at 3SBio Inc.,. He also served as a director, the president of research and development and the chief scientist of Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., . Dr. Zhu founded HanBio Therapeutics (Shanghai) Co., Ltd., and has served as the chairman of the board and the chief executive officer since then. Currently, Dr. Zhu serves as a non-executive director at Refuge Biotechnologies Inc., Verseau Therapeutics and Numab Therapeutics AG.
Dr. Zhu obtained his Ph.D. in immunology and pathology from Dalhousie University in Canada and was a post-doctorate fellow at Genentech, Inc. in the United States.